nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—ABCB1—Mitomycin—urinary bladder cancer	0.177	0.324	CbGbCtD
Buspirone—CYP3A4—Thiotepa—urinary bladder cancer	0.0804	0.147	CbGbCtD
Buspirone—CYP3A5—Etoposide—urinary bladder cancer	0.0559	0.102	CbGbCtD
Buspirone—ABCB1—Gemcitabine—urinary bladder cancer	0.051	0.0932	CbGbCtD
Buspirone—ABCB1—Cisplatin—urinary bladder cancer	0.037	0.0677	CbGbCtD
Buspirone—ABCB1—Etoposide—urinary bladder cancer	0.0364	0.0665	CbGbCtD
Buspirone—ABCB1—Doxorubicin—urinary bladder cancer	0.0248	0.0454	CbGbCtD
Buspirone—ABCB1—Methotrexate—urinary bladder cancer	0.024	0.044	CbGbCtD
Buspirone—CYP2D6—Doxorubicin—urinary bladder cancer	0.0234	0.0428	CbGbCtD
Buspirone—CYP3A4—Etoposide—urinary bladder cancer	0.0218	0.0399	CbGbCtD
Buspirone—CYP3A4—Doxorubicin—urinary bladder cancer	0.0149	0.0272	CbGbCtD
Buspirone—HTR2A—urine—urinary bladder cancer	0.00056	0.114	CbGeAlD
Buspirone—CYP3A4—urine—urinary bladder cancer	0.000518	0.105	CbGeAlD
Buspirone—CYP2D6—urine—urinary bladder cancer	0.00051	0.104	CbGeAlD
Buspirone—Drowsiness—Methotrexate—urinary bladder cancer	0.000433	0.00114	CcSEcCtD
Buspirone—Depression—Methotrexate—urinary bladder cancer	0.000431	0.00113	CcSEcCtD
Buspirone—Hypotension—Etoposide—urinary bladder cancer	0.00043	0.00113	CcSEcCtD
Buspirone—Pain—Cisplatin—urinary bladder cancer	0.00043	0.00113	CcSEcCtD
Buspirone—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000429	0.00113	CcSEcCtD
Buspirone—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000426	0.00112	CcSEcCtD
Buspirone—Dysuria—Epirubicin—urinary bladder cancer	0.000425	0.00111	CcSEcCtD
Buspirone—Dizziness—Thiotepa—urinary bladder cancer	0.000424	0.00111	CcSEcCtD
Buspirone—Urticaria—Fluorouracil—urinary bladder cancer	0.000421	0.00111	CcSEcCtD
Buspirone—Conjunctivitis—Methotrexate—urinary bladder cancer	0.00042	0.0011	CcSEcCtD
Buspirone—Pollakiuria—Epirubicin—urinary bladder cancer	0.000419	0.0011	CcSEcCtD
Buspirone—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000419	0.0011	CcSEcCtD
Buspirone—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000416	0.00109	CcSEcCtD
Buspirone—Sweating—Methotrexate—urinary bladder cancer	0.000415	0.00109	CcSEcCtD
Buspirone—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000414	0.00109	CcSEcCtD
Buspirone—Paraesthesia—Etoposide—urinary bladder cancer	0.000414	0.00109	CcSEcCtD
Buspirone—Weight increased—Epirubicin—urinary bladder cancer	0.000413	0.00108	CcSEcCtD
Buspirone—Weight decreased—Epirubicin—urinary bladder cancer	0.000411	0.00108	CcSEcCtD
Buspirone—Dyspnoea—Etoposide—urinary bladder cancer	0.000411	0.00108	CcSEcCtD
Buspirone—Somnolence—Etoposide—urinary bladder cancer	0.000409	0.00107	CcSEcCtD
Buspirone—Epistaxis—Methotrexate—urinary bladder cancer	0.000408	0.00107	CcSEcCtD
Buspirone—Vomiting—Thiotepa—urinary bladder cancer	0.000408	0.00107	CcSEcCtD
Buspirone—Drowsiness—Epirubicin—urinary bladder cancer	0.000405	0.00106	CcSEcCtD
Buspirone—Rash—Thiotepa—urinary bladder cancer	0.000404	0.00106	CcSEcCtD
Buspirone—Dermatitis—Thiotepa—urinary bladder cancer	0.000404	0.00106	CcSEcCtD
Buspirone—Headache—Thiotepa—urinary bladder cancer	0.000402	0.00105	CcSEcCtD
Buspirone—Decreased appetite—Etoposide—urinary bladder cancer	0.0004	0.00105	CcSEcCtD
Buspirone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000398	0.00104	CcSEcCtD
Buspirone—Body temperature increased—Cisplatin—urinary bladder cancer	0.000397	0.00104	CcSEcCtD
Buspirone—Fatigue—Etoposide—urinary bladder cancer	0.000397	0.00104	CcSEcCtD
Buspirone—Constipation—Etoposide—urinary bladder cancer	0.000394	0.00103	CcSEcCtD
Buspirone—Pain—Etoposide—urinary bladder cancer	0.000394	0.00103	CcSEcCtD
Buspirone—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000394	0.00103	CcSEcCtD
Buspirone—Dysuria—Doxorubicin—urinary bladder cancer	0.000393	0.00103	CcSEcCtD
Buspirone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000391	0.00103	CcSEcCtD
Buspirone—Haemoglobin—Methotrexate—urinary bladder cancer	0.00039	0.00102	CcSEcCtD
Buspirone—Haemorrhage—Methotrexate—urinary bladder cancer	0.000388	0.00102	CcSEcCtD
Buspirone—Sweating—Epirubicin—urinary bladder cancer	0.000388	0.00102	CcSEcCtD
Buspirone—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000388	0.00102	CcSEcCtD
Buspirone—Asthenia—Gemcitabine—urinary bladder cancer	0.000387	0.00102	CcSEcCtD
Buspirone—Weight increased—Doxorubicin—urinary bladder cancer	0.000382	0.001	CcSEcCtD
Buspirone—Epistaxis—Epirubicin—urinary bladder cancer	0.000382	0.001	CcSEcCtD
Buspirone—Pruritus—Gemcitabine—urinary bladder cancer	0.000382	0.001	CcSEcCtD
Buspirone—Nausea—Thiotepa—urinary bladder cancer	0.000381	0.001	CcSEcCtD
Buspirone—Weight decreased—Doxorubicin—urinary bladder cancer	0.00038	0.000997	CcSEcCtD
Buspirone—Feeling abnormal—Etoposide—urinary bladder cancer	0.00038	0.000996	CcSEcCtD
Buspirone—Pruritus—Fluorouracil—urinary bladder cancer	0.000375	0.000985	CcSEcCtD
Buspirone—Drowsiness—Doxorubicin—urinary bladder cancer	0.000375	0.000983	CcSEcCtD
Buspirone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00037	0.000972	CcSEcCtD
Buspirone—Bradycardia—Epirubicin—urinary bladder cancer	0.00037	0.000971	CcSEcCtD
Buspirone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000369	0.000969	CcSEcCtD
Buspirone—Urticaria—Etoposide—urinary bladder cancer	0.000366	0.00096	CcSEcCtD
Buspirone—Haemoglobin—Epirubicin—urinary bladder cancer	0.000365	0.000959	CcSEcCtD
Buspirone—Body temperature increased—Etoposide—urinary bladder cancer	0.000364	0.000956	CcSEcCtD
Buspirone—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000364	0.000956	CcSEcCtD
Buspirone—Haemorrhage—Epirubicin—urinary bladder cancer	0.000363	0.000954	CcSEcCtD
Buspirone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000363	0.000952	CcSEcCtD
Buspirone—Tinnitus—Methotrexate—urinary bladder cancer	0.000362	0.00095	CcSEcCtD
Buspirone—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000362	0.000949	CcSEcCtD
Buspirone—Asthenia—Cisplatin—urinary bladder cancer	0.000361	0.000947	CcSEcCtD
Buspirone—Sweating—Doxorubicin—urinary bladder cancer	0.000359	0.000942	CcSEcCtD
Buspirone—Epistaxis—Doxorubicin—urinary bladder cancer	0.000353	0.000927	CcSEcCtD
Buspirone—Dizziness—Fluorouracil—urinary bladder cancer	0.000351	0.00092	CcSEcCtD
Buspirone—Chills—Methotrexate—urinary bladder cancer	0.000348	0.000914	CcSEcCtD
Buspirone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000344	0.000903	CcSEcCtD
Buspirone—Alopecia—Methotrexate—urinary bladder cancer	0.000343	0.000901	CcSEcCtD
Buspirone—Vomiting—Gemcitabine—urinary bladder cancer	0.000343	0.0009	CcSEcCtD
Buspirone—Bradycardia—Doxorubicin—urinary bladder cancer	0.000342	0.000898	CcSEcCtD
Buspirone—Rash—Gemcitabine—urinary bladder cancer	0.00034	0.000893	CcSEcCtD
Buspirone—Dermatitis—Gemcitabine—urinary bladder cancer	0.00034	0.000892	CcSEcCtD
Buspirone—Hypersensitivity—Etoposide—urinary bladder cancer	0.000339	0.000891	CcSEcCtD
Buspirone—Tinnitus—Epirubicin—urinary bladder cancer	0.000339	0.000889	CcSEcCtD
Buspirone—Erythema—Methotrexate—urinary bladder cancer	0.000338	0.000887	CcSEcCtD
Buspirone—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000338	0.000887	CcSEcCtD
Buspirone—Headache—Gemcitabine—urinary bladder cancer	0.000338	0.000887	CcSEcCtD
Buspirone—Flushing—Epirubicin—urinary bladder cancer	0.000337	0.000885	CcSEcCtD
Buspirone—Vomiting—Fluorouracil—urinary bladder cancer	0.000337	0.000885	CcSEcCtD
Buspirone—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000336	0.000882	CcSEcCtD
Buspirone—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000335	0.000878	CcSEcCtD
Buspirone—Rash—Fluorouracil—urinary bladder cancer	0.000334	0.000878	CcSEcCtD
Buspirone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000334	0.000877	CcSEcCtD
Buspirone—Headache—Fluorouracil—urinary bladder cancer	0.000332	0.000872	CcSEcCtD
Buspirone—Dysgeusia—Methotrexate—urinary bladder cancer	0.000331	0.000869	CcSEcCtD
Buspirone—Asthenia—Etoposide—urinary bladder cancer	0.00033	0.000867	CcSEcCtD
Buspirone—Chills—Epirubicin—urinary bladder cancer	0.000326	0.000856	CcSEcCtD
Buspirone—Pruritus—Etoposide—urinary bladder cancer	0.000326	0.000855	CcSEcCtD
Buspirone—Alopecia—Epirubicin—urinary bladder cancer	0.000321	0.000843	CcSEcCtD
Buspirone—Nausea—Gemcitabine—urinary bladder cancer	0.00032	0.000841	CcSEcCtD
Buspirone—Vomiting—Cisplatin—urinary bladder cancer	0.00032	0.000839	CcSEcCtD
Buspirone—Vision blurred—Methotrexate—urinary bladder cancer	0.000319	0.000836	CcSEcCtD
Buspirone—Rash—Cisplatin—urinary bladder cancer	0.000317	0.000832	CcSEcCtD
Buspirone—Dermatitis—Cisplatin—urinary bladder cancer	0.000317	0.000831	CcSEcCtD
Buspirone—Erythema—Epirubicin—urinary bladder cancer	0.000316	0.00083	CcSEcCtD
Buspirone—Diarrhoea—Etoposide—urinary bladder cancer	0.000315	0.000827	CcSEcCtD
Buspirone—Nausea—Fluorouracil—urinary bladder cancer	0.000315	0.000827	CcSEcCtD
Buspirone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000314	0.000823	CcSEcCtD
Buspirone—Tinnitus—Doxorubicin—urinary bladder cancer	0.000314	0.000823	CcSEcCtD
Buspirone—Flushing—Doxorubicin—urinary bladder cancer	0.000312	0.000819	CcSEcCtD
Buspirone—Flatulence—Epirubicin—urinary bladder cancer	0.000312	0.000818	CcSEcCtD
Buspirone—Tension—Epirubicin—urinary bladder cancer	0.00031	0.000815	CcSEcCtD
Buspirone—Dysgeusia—Epirubicin—urinary bladder cancer	0.00031	0.000813	CcSEcCtD
Buspirone—Nervousness—Epirubicin—urinary bladder cancer	0.000307	0.000806	CcSEcCtD
Buspirone—Malaise—Methotrexate—urinary bladder cancer	0.000305	0.0008	CcSEcCtD
Buspirone—Dizziness—Etoposide—urinary bladder cancer	0.000305	0.000799	CcSEcCtD
Buspirone—Muscle spasms—Epirubicin—urinary bladder cancer	0.000304	0.000798	CcSEcCtD
Buspirone—Vertigo—Methotrexate—urinary bladder cancer	0.000304	0.000797	CcSEcCtD
Buspirone—Leukopenia—Methotrexate—urinary bladder cancer	0.000303	0.000794	CcSEcCtD
Buspirone—Chills—Doxorubicin—urinary bladder cancer	0.000302	0.000792	CcSEcCtD
Buspirone—Nausea—Cisplatin—urinary bladder cancer	0.000299	0.000784	CcSEcCtD
Buspirone—Vision blurred—Epirubicin—urinary bladder cancer	0.000298	0.000782	CcSEcCtD
Buspirone—Alopecia—Doxorubicin—urinary bladder cancer	0.000297	0.00078	CcSEcCtD
Buspirone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000294	0.00077	CcSEcCtD
Buspirone—Convulsion—Methotrexate—urinary bladder cancer	0.000293	0.000769	CcSEcCtD
Buspirone—Vomiting—Etoposide—urinary bladder cancer	0.000293	0.000769	CcSEcCtD
Buspirone—Erythema—Doxorubicin—urinary bladder cancer	0.000293	0.000768	CcSEcCtD
Buspirone—Agitation—Epirubicin—urinary bladder cancer	0.000291	0.000763	CcSEcCtD
Buspirone—Rash—Etoposide—urinary bladder cancer	0.00029	0.000762	CcSEcCtD
Buspirone—Dermatitis—Etoposide—urinary bladder cancer	0.00029	0.000761	CcSEcCtD
Buspirone—Headache—Etoposide—urinary bladder cancer	0.000289	0.000757	CcSEcCtD
Buspirone—Flatulence—Doxorubicin—urinary bladder cancer	0.000288	0.000757	CcSEcCtD
Buspirone—Myalgia—Methotrexate—urinary bladder cancer	0.000288	0.000755	CcSEcCtD
Buspirone—Arthralgia—Methotrexate—urinary bladder cancer	0.000288	0.000755	CcSEcCtD
Buspirone—Chest pain—Methotrexate—urinary bladder cancer	0.000288	0.000755	CcSEcCtD
Buspirone—Tension—Doxorubicin—urinary bladder cancer	0.000287	0.000754	CcSEcCtD
Buspirone—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000287	0.000752	CcSEcCtD
Buspirone—Malaise—Epirubicin—urinary bladder cancer	0.000285	0.000749	CcSEcCtD
Buspirone—Discomfort—Methotrexate—urinary bladder cancer	0.000284	0.000746	CcSEcCtD
Buspirone—Nervousness—Doxorubicin—urinary bladder cancer	0.000284	0.000746	CcSEcCtD
Buspirone—Vertigo—Epirubicin—urinary bladder cancer	0.000284	0.000746	CcSEcCtD
Buspirone—Syncope—Epirubicin—urinary bladder cancer	0.000284	0.000745	CcSEcCtD
Buspirone—Leukopenia—Epirubicin—urinary bladder cancer	0.000283	0.000743	CcSEcCtD
Buspirone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000281	0.000739	CcSEcCtD
Buspirone—Palpitations—Epirubicin—urinary bladder cancer	0.00028	0.000734	CcSEcCtD
Buspirone—Confusional state—Methotrexate—urinary bladder cancer	0.000278	0.00073	CcSEcCtD
Buspirone—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000278	0.00073	CcSEcCtD
Buspirone—Vision blurred—Doxorubicin—urinary bladder cancer	0.000276	0.000724	CcSEcCtD
Buspirone—Convulsion—Epirubicin—urinary bladder cancer	0.000274	0.000719	CcSEcCtD
Buspirone—Nausea—Etoposide—urinary bladder cancer	0.000274	0.000718	CcSEcCtD
Buspirone—Hypertension—Epirubicin—urinary bladder cancer	0.000273	0.000717	CcSEcCtD
Buspirone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000272	0.000713	CcSEcCtD
Buspirone—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00027	0.000709	CcSEcCtD
Buspirone—Chest pain—Epirubicin—urinary bladder cancer	0.000269	0.000707	CcSEcCtD
Buspirone—Arthralgia—Epirubicin—urinary bladder cancer	0.000269	0.000707	CcSEcCtD
Buspirone—Myalgia—Epirubicin—urinary bladder cancer	0.000269	0.000707	CcSEcCtD
Buspirone—Agitation—Doxorubicin—urinary bladder cancer	0.000269	0.000706	CcSEcCtD
Buspirone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000267	0.0007	CcSEcCtD
Buspirone—HTR2B—smooth muscle tissue—urinary bladder cancer	0.000267	0.0542	CbGeAlD
Buspirone—Discomfort—Epirubicin—urinary bladder cancer	0.000266	0.000698	CcSEcCtD
Buspirone—Malaise—Doxorubicin—urinary bladder cancer	0.000264	0.000693	CcSEcCtD
Buspirone—Dry mouth—Epirubicin—urinary bladder cancer	0.000263	0.000691	CcSEcCtD
Buspirone—Vertigo—Doxorubicin—urinary bladder cancer	0.000263	0.00069	CcSEcCtD
Buspirone—Anorexia—Methotrexate—urinary bladder cancer	0.000263	0.00069	CcSEcCtD
Buspirone—Syncope—Doxorubicin—urinary bladder cancer	0.000263	0.000689	CcSEcCtD
Buspirone—Leukopenia—Doxorubicin—urinary bladder cancer	0.000262	0.000688	CcSEcCtD
Buspirone—Confusional state—Epirubicin—urinary bladder cancer	0.00026	0.000683	CcSEcCtD
Buspirone—Palpitations—Doxorubicin—urinary bladder cancer	0.000259	0.000679	CcSEcCtD
Buspirone—Oedema—Epirubicin—urinary bladder cancer	0.000258	0.000678	CcSEcCtD
Buspirone—Hypotension—Methotrexate—urinary bladder cancer	0.000258	0.000677	CcSEcCtD
Buspirone—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000257	0.000675	CcSEcCtD
Buspirone—Shock—Epirubicin—urinary bladder cancer	0.000254	0.000667	CcSEcCtD
Buspirone—Convulsion—Doxorubicin—urinary bladder cancer	0.000254	0.000666	CcSEcCtD
Buspirone—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000253	0.000663	CcSEcCtD
Buspirone—Hypertension—Doxorubicin—urinary bladder cancer	0.000253	0.000663	CcSEcCtD
Buspirone—Tachycardia—Epirubicin—urinary bladder cancer	0.000252	0.000661	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000251	0.00066	CcSEcCtD
Buspirone—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00025	0.000655	CcSEcCtD
Buspirone—Insomnia—Methotrexate—urinary bladder cancer	0.00025	0.000655	CcSEcCtD
Buspirone—Chest pain—Doxorubicin—urinary bladder cancer	0.000249	0.000654	CcSEcCtD
Buspirone—Myalgia—Doxorubicin—urinary bladder cancer	0.000249	0.000654	CcSEcCtD
Buspirone—Arthralgia—Doxorubicin—urinary bladder cancer	0.000249	0.000654	CcSEcCtD
Buspirone—CYP3A5—prostate gland—urinary bladder cancer	0.000248	0.0504	CbGeAlD
Buspirone—Paraesthesia—Methotrexate—urinary bladder cancer	0.000248	0.00065	CcSEcCtD
Buspirone—Discomfort—Doxorubicin—urinary bladder cancer	0.000246	0.000646	CcSEcCtD
Buspirone—Anorexia—Epirubicin—urinary bladder cancer	0.000246	0.000646	CcSEcCtD
Buspirone—Dyspnoea—Methotrexate—urinary bladder cancer	0.000246	0.000646	CcSEcCtD
Buspirone—Somnolence—Methotrexate—urinary bladder cancer	0.000245	0.000644	CcSEcCtD
Buspirone—Dry mouth—Doxorubicin—urinary bladder cancer	0.000244	0.00064	CcSEcCtD
Buspirone—Dyspepsia—Methotrexate—urinary bladder cancer	0.000243	0.000637	CcSEcCtD
Buspirone—Hypotension—Epirubicin—urinary bladder cancer	0.000241	0.000633	CcSEcCtD
Buspirone—Confusional state—Doxorubicin—urinary bladder cancer	0.000241	0.000632	CcSEcCtD
Buspirone—Decreased appetite—Methotrexate—urinary bladder cancer	0.00024	0.000629	CcSEcCtD
Buspirone—Oedema—Doxorubicin—urinary bladder cancer	0.000239	0.000627	CcSEcCtD
Buspirone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000238	0.000625	CcSEcCtD
Buspirone—Fatigue—Methotrexate—urinary bladder cancer	0.000238	0.000624	CcSEcCtD
Buspirone—Pain—Methotrexate—urinary bladder cancer	0.000236	0.000619	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000235	0.000617	CcSEcCtD
Buspirone—Shock—Doxorubicin—urinary bladder cancer	0.000235	0.000617	CcSEcCtD
Buspirone—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000234	0.000614	CcSEcCtD
Buspirone—Insomnia—Epirubicin—urinary bladder cancer	0.000234	0.000613	CcSEcCtD
Buspirone—Tachycardia—Doxorubicin—urinary bladder cancer	0.000233	0.000612	CcSEcCtD
Buspirone—Paraesthesia—Epirubicin—urinary bladder cancer	0.000232	0.000608	CcSEcCtD
Buspirone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000231	0.000606	CcSEcCtD
Buspirone—Dyspnoea—Epirubicin—urinary bladder cancer	0.00023	0.000604	CcSEcCtD
Buspirone—HTR1A—renal system—urinary bladder cancer	0.00023	0.0467	CbGeAlD
Buspirone—Somnolence—Epirubicin—urinary bladder cancer	0.00023	0.000602	CcSEcCtD
Buspirone—Anorexia—Doxorubicin—urinary bladder cancer	0.000228	0.000598	CcSEcCtD
Buspirone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000227	0.000597	CcSEcCtD
Buspirone—Dyspepsia—Epirubicin—urinary bladder cancer	0.000227	0.000596	CcSEcCtD
Buspirone—Decreased appetite—Epirubicin—urinary bladder cancer	0.000224	0.000589	CcSEcCtD
Buspirone—Hypotension—Doxorubicin—urinary bladder cancer	0.000223	0.000586	CcSEcCtD
Buspirone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000223	0.000585	CcSEcCtD
Buspirone—Fatigue—Epirubicin—urinary bladder cancer	0.000223	0.000584	CcSEcCtD
Buspirone—Constipation—Epirubicin—urinary bladder cancer	0.000221	0.000579	CcSEcCtD
Buspirone—Pain—Epirubicin—urinary bladder cancer	0.000221	0.000579	CcSEcCtD
Buspirone—Urticaria—Methotrexate—urinary bladder cancer	0.000219	0.000575	CcSEcCtD
Buspirone—Body temperature increased—Methotrexate—urinary bladder cancer	0.000218	0.000572	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000218	0.000571	CcSEcCtD
Buspirone—Insomnia—Doxorubicin—urinary bladder cancer	0.000216	0.000567	CcSEcCtD
Buspirone—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000215	0.000563	CcSEcCtD
Buspirone—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000213	0.000559	CcSEcCtD
Buspirone—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000213	0.000558	CcSEcCtD
Buspirone—Somnolence—Doxorubicin—urinary bladder cancer	0.000212	0.000557	CcSEcCtD
Buspirone—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00021	0.000552	CcSEcCtD
Buspirone—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000208	0.000545	CcSEcCtD
Buspirone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000206	0.000541	CcSEcCtD
Buspirone—Fatigue—Doxorubicin—urinary bladder cancer	0.000206	0.000541	CcSEcCtD
Buspirone—HTR2B—female reproductive system—urinary bladder cancer	0.000205	0.0418	CbGeAlD
Buspirone—Urticaria—Epirubicin—urinary bladder cancer	0.000205	0.000538	CcSEcCtD
Buspirone—Pain—Doxorubicin—urinary bladder cancer	0.000204	0.000536	CcSEcCtD
Buspirone—Constipation—Doxorubicin—urinary bladder cancer	0.000204	0.000536	CcSEcCtD
Buspirone—Body temperature increased—Epirubicin—urinary bladder cancer	0.000204	0.000536	CcSEcCtD
Buspirone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000203	0.000533	CcSEcCtD
Buspirone—Asthenia—Methotrexate—urinary bladder cancer	0.000198	0.000519	CcSEcCtD
Buspirone—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000197	0.000517	CcSEcCtD
Buspirone—Pruritus—Methotrexate—urinary bladder cancer	0.000195	0.000512	CcSEcCtD
Buspirone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00019	0.000499	CcSEcCtD
Buspirone—Urticaria—Doxorubicin—urinary bladder cancer	0.00019	0.000498	CcSEcCtD
Buspirone—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000189	0.000496	CcSEcCtD
Buspirone—Diarrhoea—Methotrexate—urinary bladder cancer	0.000189	0.000495	CcSEcCtD
Buspirone—HTR2B—vagina—urinary bladder cancer	0.000186	0.0378	CbGeAlD
Buspirone—Asthenia—Epirubicin—urinary bladder cancer	0.000185	0.000486	CcSEcCtD
Buspirone—Pruritus—Epirubicin—urinary bladder cancer	0.000183	0.000479	CcSEcCtD
Buspirone—Dizziness—Methotrexate—urinary bladder cancer	0.000182	0.000479	CcSEcCtD
Buspirone—Diarrhoea—Epirubicin—urinary bladder cancer	0.000177	0.000464	CcSEcCtD
Buspirone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000176	0.000462	CcSEcCtD
Buspirone—Vomiting—Methotrexate—urinary bladder cancer	0.000175	0.00046	CcSEcCtD
Buspirone—Rash—Methotrexate—urinary bladder cancer	0.000174	0.000457	CcSEcCtD
Buspirone—Dermatitis—Methotrexate—urinary bladder cancer	0.000174	0.000456	CcSEcCtD
Buspirone—Headache—Methotrexate—urinary bladder cancer	0.000173	0.000454	CcSEcCtD
Buspirone—Asthenia—Doxorubicin—urinary bladder cancer	0.000171	0.00045	CcSEcCtD
Buspirone—Dizziness—Epirubicin—urinary bladder cancer	0.000171	0.000448	CcSEcCtD
Buspirone—Pruritus—Doxorubicin—urinary bladder cancer	0.000169	0.000444	CcSEcCtD
Buspirone—CYP3A5—renal system—urinary bladder cancer	0.000169	0.0343	CbGeAlD
Buspirone—Vomiting—Epirubicin—urinary bladder cancer	0.000164	0.000431	CcSEcCtD
Buspirone—Nausea—Methotrexate—urinary bladder cancer	0.000164	0.00043	CcSEcCtD
Buspirone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000163	0.000429	CcSEcCtD
Buspirone—Rash—Epirubicin—urinary bladder cancer	0.000163	0.000427	CcSEcCtD
Buspirone—Dermatitis—Epirubicin—urinary bladder cancer	0.000163	0.000427	CcSEcCtD
Buspirone—Headache—Epirubicin—urinary bladder cancer	0.000162	0.000424	CcSEcCtD
Buspirone—Dizziness—Doxorubicin—urinary bladder cancer	0.000158	0.000415	CcSEcCtD
Buspirone—Nausea—Epirubicin—urinary bladder cancer	0.000153	0.000402	CcSEcCtD
Buspirone—Vomiting—Doxorubicin—urinary bladder cancer	0.000152	0.000399	CcSEcCtD
Buspirone—Rash—Doxorubicin—urinary bladder cancer	0.000151	0.000395	CcSEcCtD
Buspirone—Dermatitis—Doxorubicin—urinary bladder cancer	0.00015	0.000395	CcSEcCtD
Buspirone—Headache—Doxorubicin—urinary bladder cancer	0.00015	0.000393	CcSEcCtD
Buspirone—HTR2A—epithelium—urinary bladder cancer	0.000148	0.03	CbGeAlD
Buspirone—HTR2A—smooth muscle tissue—urinary bladder cancer	0.000142	0.0289	CbGeAlD
Buspirone—Nausea—Doxorubicin—urinary bladder cancer	0.000142	0.000372	CcSEcCtD
Buspirone—HTR2A—renal system—urinary bladder cancer	0.000137	0.0278	CbGeAlD
Buspirone—ABCB1—prostate gland—urinary bladder cancer	0.000132	0.0268	CbGeAlD
Buspirone—CYP3A4—renal system—urinary bladder cancer	0.000127	0.0258	CbGeAlD
Buspirone—CYP2D6—renal system—urinary bladder cancer	0.000125	0.0254	CbGeAlD
Buspirone—CYP3A5—vagina—urinary bladder cancer	0.000122	0.0249	CbGeAlD
Buspirone—HTR2B—lymph node—urinary bladder cancer	0.00012	0.0244	CbGeAlD
Buspirone—ABCB1—seminal vesicle—urinary bladder cancer	0.000111	0.0226	CbGeAlD
Buspirone—HTR2A—female reproductive system—urinary bladder cancer	0.00011	0.0223	CbGeAlD
Buspirone—CYP3A4—female reproductive system—urinary bladder cancer	0.000102	0.0206	CbGeAlD
Buspirone—CYP2D6—female reproductive system—urinary bladder cancer	0.0001	0.0203	CbGeAlD
Buspirone—HTR2A—vagina—urinary bladder cancer	9.92e-05	0.0202	CbGeAlD
Buspirone—ABCB1—epithelium—urinary bladder cancer	9.68e-05	0.0197	CbGeAlD
Buspirone—ABCB1—renal system—urinary bladder cancer	8.98e-05	0.0182	CbGeAlD
Buspirone—ABCB1—urethra—urinary bladder cancer	8.82e-05	0.0179	CbGeAlD
Buspirone—ABCB1—female reproductive system—urinary bladder cancer	7.19e-05	0.0146	CbGeAlD
Buspirone—ABCB1—vagina—urinary bladder cancer	6.5e-05	0.0132	CbGeAlD
Buspirone—ABCB1—lymph node—urinary bladder cancer	4.21e-05	0.00855	CbGeAlD
Buspirone—HTR2B—Signaling Pathways—S100B—urinary bladder cancer	2.97e-05	0.000441	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—TYMP—urinary bladder cancer	2.97e-05	0.000441	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.93e-05	0.000435	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	2.93e-05	0.000435	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—RBX1—urinary bladder cancer	2.92e-05	0.000433	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—RHOA—urinary bladder cancer	2.89e-05	0.000428	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.88e-05	0.000428	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—RBX1—urinary bladder cancer	2.87e-05	0.000426	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.86e-05	0.000424	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.85e-05	0.000423	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—RHOA—urinary bladder cancer	2.82e-05	0.000418	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	2.81e-05	0.000417	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—S100B—urinary bladder cancer	2.76e-05	0.00041	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TSC1—urinary bladder cancer	2.74e-05	0.000407	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.72e-05	0.000404	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TSC1—urinary bladder cancer	2.7e-05	0.000401	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—NAT2—urinary bladder cancer	2.69e-05	0.000399	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NCOR1—urinary bladder cancer	2.67e-05	0.000397	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.64e-05	0.000392	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—RHOA—urinary bladder cancer	2.62e-05	0.000389	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—JAG1—urinary bladder cancer	2.61e-05	0.000388	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—TYMS—urinary bladder cancer	2.61e-05	0.000388	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—IL2—urinary bladder cancer	2.6e-05	0.000386	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	2.58e-05	0.000383	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	2.58e-05	0.000383	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—JAG1—urinary bladder cancer	2.57e-05	0.000382	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.54e-05	0.000377	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.53e-05	0.000376	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—RHOA—urinary bladder cancer	2.51e-05	0.000373	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.49e-05	0.00037	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NCOR1—urinary bladder cancer	2.49e-05	0.000369	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—CXCL8—urinary bladder cancer	2.47e-05	0.000367	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—GPX1—urinary bladder cancer	2.47e-05	0.000367	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.46e-05	0.000365	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.43e-05	0.000361	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.43e-05	0.000361	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	2.43e-05	0.00036	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—IL2—urinary bladder cancer	2.42e-05	0.000359	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—S100B—urinary bladder cancer	2.41e-05	0.000358	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—IL2—urinary bladder cancer	2.36e-05	0.000351	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TERT—urinary bladder cancer	2.35e-05	0.000349	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.32e-05	0.000344	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—CXCL8—urinary bladder cancer	2.3e-05	0.000342	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—RHOA—urinary bladder cancer	2.28e-05	0.000339	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	2.28e-05	0.000339	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.28e-05	0.000338	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.28e-05	0.000338	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.21e-05	0.000328	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—RHOA—urinary bladder cancer	2.21e-05	0.000328	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.21e-05	0.000328	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—IL2—urinary bladder cancer	2.2e-05	0.000326	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TERT—urinary bladder cancer	2.19e-05	0.000325	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—RHOA—urinary bladder cancer	2.17e-05	0.000323	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NCOR1—urinary bladder cancer	2.17e-05	0.000322	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—FGFR3—urinary bladder cancer	2.16e-05	0.000321	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.15e-05	0.000319	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.15e-05	0.000319	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—S100B—urinary bladder cancer	2.12e-05	0.000314	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—IL2—urinary bladder cancer	2.11e-05	0.000313	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—ESR1—urinary bladder cancer	2.1e-05	0.000311	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.08e-05	0.000309	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—S100B—urinary bladder cancer	2.08e-05	0.000309	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.07e-05	0.000307	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	2.03e-05	0.000301	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—FGFR3—urinary bladder cancer	2.01e-05	0.000298	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—RHOA—urinary bladder cancer	2.01e-05	0.000298	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—CXCL8—urinary bladder cancer	2e-05	0.000298	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—RHOA—urinary bladder cancer	1.97e-05	0.000293	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—ESR1—urinary bladder cancer	1.95e-05	0.00029	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.94e-05	0.000288	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.94e-05	0.000288	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—IL2—urinary bladder cancer	1.92e-05	0.000284	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TERT—urinary bladder cancer	1.91e-05	0.000283	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.91e-05	0.000283	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NCOR1—urinary bladder cancer	1.9e-05	0.000282	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.89e-05	0.00028	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NCOR1—urinary bladder cancer	1.87e-05	0.000278	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.87e-05	0.000277	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.87e-05	0.000277	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—IL2—urinary bladder cancer	1.85e-05	0.000275	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.85e-05	0.000275	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CREBBP—urinary bladder cancer	1.84e-05	0.000273	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.84e-05	0.000273	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—IL2—urinary bladder cancer	1.82e-05	0.000271	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IGF1—urinary bladder cancer	1.82e-05	0.00027	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—EGFR—urinary bladder cancer	1.81e-05	0.000268	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.79e-05	0.000265	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.78e-05	0.000264	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—CXCL8—urinary bladder cancer	1.76e-05	0.000261	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.76e-05	0.000261	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.75e-05	0.00026	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—FGFR3—urinary bladder cancer	1.75e-05	0.00026	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—CXCL8—urinary bladder cancer	1.73e-05	0.000257	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.73e-05	0.000257	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CREBBP—urinary bladder cancer	1.71e-05	0.000254	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—KRAS—urinary bladder cancer	1.71e-05	0.000253	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ESR1—urinary bladder cancer	1.7e-05	0.000253	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IGF1—urinary bladder cancer	1.69e-05	0.000251	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—IL2—urinary bladder cancer	1.68e-05	0.00025	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—EGFR—urinary bladder cancer	1.68e-05	0.00025	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TERT—urinary bladder cancer	1.68e-05	0.000249	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—RHOA—urinary bladder cancer	1.66e-05	0.000247	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—IL2—urinary bladder cancer	1.66e-05	0.000246	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TERT—urinary bladder cancer	1.65e-05	0.000245	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.65e-05	0.000245	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—KRAS—urinary bladder cancer	1.59e-05	0.000236	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—RHOA—urinary bladder cancer	1.55e-05	0.00023	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—ERBB2—urinary bladder cancer	1.54e-05	0.000229	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—FGFR3—urinary bladder cancer	1.54e-05	0.000228	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.53e-05	0.000227	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.52e-05	0.000225	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—FGFR3—urinary bladder cancer	1.51e-05	0.000225	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ESR1—urinary bladder cancer	1.49e-05	0.000222	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CREBBP—urinary bladder cancer	1.49e-05	0.000221	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IGF1—urinary bladder cancer	1.47e-05	0.000219	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ESR1—urinary bladder cancer	1.47e-05	0.000218	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—EGFR—urinary bladder cancer	1.47e-05	0.000218	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CXCL8—urinary bladder cancer	1.46e-05	0.000217	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.46e-05	0.000216	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—HRAS—urinary bladder cancer	1.45e-05	0.000215	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.44e-05	0.000214	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—ERBB2—urinary bladder cancer	1.43e-05	0.000213	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.42e-05	0.000211	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.41e-05	0.000209	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.41e-05	0.000209	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.4e-05	0.000208	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.4e-05	0.000208	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IL2—urinary bladder cancer	1.4e-05	0.000207	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—KRAS—urinary bladder cancer	1.38e-05	0.000206	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.36e-05	0.000202	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CCND1—urinary bladder cancer	1.36e-05	0.000202	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CXCL8—urinary bladder cancer	1.36e-05	0.000202	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—HRAS—urinary bladder cancer	1.35e-05	0.0002	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—RHOA—urinary bladder cancer	1.35e-05	0.0002	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.35e-05	0.0002	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.34e-05	0.000199	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.34e-05	0.000199	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.33e-05	0.000197	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.33e-05	0.000197	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.32e-05	0.000197	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MMP9—urinary bladder cancer	1.32e-05	0.000196	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CDKN1A—urinary bladder cancer	1.32e-05	0.000195	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PTEN—urinary bladder cancer	1.31e-05	0.000195	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CREBBP—urinary bladder cancer	1.31e-05	0.000194	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IL2—urinary bladder cancer	1.3e-05	0.000193	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IGF1—urinary bladder cancer	1.29e-05	0.000192	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CREBBP—urinary bladder cancer	1.29e-05	0.000191	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—EGFR—urinary bladder cancer	1.29e-05	0.000191	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.28e-05	0.000191	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IGF1—urinary bladder cancer	1.27e-05	0.000189	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.27e-05	0.000189	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PTEN—urinary bladder cancer	1.27e-05	0.000188	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CCND1—urinary bladder cancer	1.27e-05	0.000188	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—EGFR—urinary bladder cancer	1.27e-05	0.000188	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EP300—urinary bladder cancer	1.25e-05	0.000186	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ERBB2—urinary bladder cancer	1.25e-05	0.000185	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.25e-05	0.000185	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.24e-05	0.000185	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MMP9—urinary bladder cancer	1.23e-05	0.000182	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.22e-05	0.000182	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PTEN—urinary bladder cancer	1.22e-05	0.000181	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—SRC—urinary bladder cancer	1.22e-05	0.000181	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—KRAS—urinary bladder cancer	1.22e-05	0.00018	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—EP300—urinary bladder cancer	1.21e-05	0.00018	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—KRAS—urinary bladder cancer	1.2e-05	0.000178	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—RHOA—urinary bladder cancer	1.18e-05	0.000176	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CXCL8—urinary bladder cancer	1.18e-05	0.000176	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—HRAS—urinary bladder cancer	1.18e-05	0.000175	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.17e-05	0.000174	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—RHOA—urinary bladder cancer	1.17e-05	0.000173	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EP300—urinary bladder cancer	1.17e-05	0.000173	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—SRC—urinary bladder cancer	1.13e-05	0.000168	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IL2—urinary bladder cancer	1.13e-05	0.000168	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.13e-05	0.000168	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CCND1—urinary bladder cancer	1.1e-05	0.000164	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	1.1e-05	0.000163	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MYC—urinary bladder cancer	1.09e-05	0.000162	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ERBB2—urinary bladder cancer	1.08e-05	0.00016	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MMP9—urinary bladder cancer	1.07e-05	0.000159	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EGFR—urinary bladder cancer	1.07e-05	0.000158	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CDKN1A—urinary bladder cancer	1.07e-05	0.000158	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PTEN—urinary bladder cancer	1.06e-05	0.000158	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.05e-05	0.000156	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	1.04e-05	0.000154	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	1.03e-05	0.000153	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CXCL8—urinary bladder cancer	1.02e-05	0.000152	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—HRAS—urinary bladder cancer	1.02e-05	0.000151	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EP300—urinary bladder cancer	1.02e-05	0.000151	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MYC—urinary bladder cancer	1.02e-05	0.000151	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.01e-05	0.00015	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—KRAS—urinary bladder cancer	1.01e-05	0.00015	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL2—urinary bladder cancer	9.94e-06	0.000148	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EGFR—urinary bladder cancer	9.93e-06	0.000147	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—SRC—urinary bladder cancer	9.88e-06	0.000147	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	9.78e-06	0.000145	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CREBBP—urinary bladder cancer	9.69e-06	0.000144	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	9.69e-06	0.000144	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	9.53e-06	0.000142	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PPARG—urinary bladder cancer	9.51e-06	0.000141	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	9.44e-06	0.00014	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	9.4e-06	0.00014	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—KRAS—urinary bladder cancer	9.38e-06	0.000139	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	9.37e-06	0.000139	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	9.35e-06	0.000139	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	9.25e-06	0.000137	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	9.22e-06	0.000137	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	9.2e-06	0.000137	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTEN—urinary bladder cancer	9.17e-06	0.000136	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	9.13e-06	0.000136	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TP53—urinary bladder cancer	8.96e-06	0.000133	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EP300—urinary bladder cancer	8.92e-06	0.000132	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MYC—urinary bladder cancer	8.85e-06	0.000131	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.78e-06	0.00013	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	8.77e-06	0.00013	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—EP300—urinary bladder cancer	8.75e-06	0.00013	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.67e-06	0.000129	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.67e-06	0.000129	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SRC—urinary bladder cancer	8.67e-06	0.000129	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EGFR—urinary bladder cancer	8.66e-06	0.000129	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—HRAS—urinary bladder cancer	8.57e-06	0.000127	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	8.53e-06	0.000127	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TP53—urinary bladder cancer	8.34e-06	0.000124	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	8.31e-06	0.000123	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—KRAS—urinary bladder cancer	8.18e-06	0.000121	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	8.16e-06	0.000121	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—HRAS—urinary bladder cancer	7.98e-06	0.000118	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTGS2—urinary bladder cancer	7.94e-06	0.000118	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MYC—urinary bladder cancer	7.77e-06	0.000115	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.67e-06	0.000114	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	7.65e-06	0.000114	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	7.6e-06	0.000113	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	7.48e-06	0.000111	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	7.48e-06	0.000111	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TP53—urinary bladder cancer	7.27e-06	0.000108	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	7.18e-06	0.000107	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	7.06e-06	0.000105	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—HRAS—urinary bladder cancer	6.95e-06	0.000103	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTEN—urinary bladder cancer	6.92e-06	0.000103	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—EP300—urinary bladder cancer	6.6e-06	9.8e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTEN—urinary bladder cancer	6.52e-06	9.68e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TP53—urinary bladder cancer	6.38e-06	9.47e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	6.28e-06	9.32e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—EP300—urinary bladder cancer	6.22e-06	9.24e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.22e-06	9.23e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	6.1e-06	9.06e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	6e-06	8.91e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.97e-06	8.87e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.89e-06	7.26e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.26e-06	6.33e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.07e-06	6.04e-05	CbGpPWpGaD
